TCL Archive NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial. April 20, 2007
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014